Please ensure Javascript is enabled for purposes of website accessibility

Why Zynex Stock Is Dropping Today

By Prosper Junior Bakiny – Jul 15, 2020 at 10:37AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The company announced the pricing of a public offering of common stock.

What happened?

Shares of Zynex (ZYXI -4.44%), a medical device manufacturer, are down by 9.9% as of 11:23 a.m. EDT on Wednesday, after the company announced the pricing of a public offering of common stock after the market closed on Tuesday. Zynex's decision to sell additional shares isn't sitting well with investors. 

So what

Zynex expects to sell 2.5 million shares for $22 per share in this public offering of common stock. Note that half of these shares are being sold directly by Zynex, while the remaining shares are being sold by certain stockholders. The company is granting underwriters a 30-day option to acquire an additional 187,500 shares, while the stockholders participating in this transaction are also giving underwriters the option of buying 187,500 of their shares of common stock.

Zynex expects to raise $27.5 million (in gross proceeds) through this offering of common stock, which should close by July 17. The company will not receive any proceeds from the sale of the shares that are being offered by the stockholders.

Five downward pointing arrows on a blackboard.

Image source: Getty Images.

Now what

At the close of the previous trading session, Zynex's shares were worth $26.22 apiece. And considering the company priced its public offering at $22 per share, it isn't surprising that investors responded by selling off its stock. At writing, Zynex's stock price is down to $23.49. The healthcare company expects to use the proceeds from this transaction to ramp up its marketing efforts and for working capital purposes, among other things.

This slump may present an opportunity for interested investors to purchase shares of Zynex. The company's business has been picking up steam since several states have started reopening their economies. As such, Zynex's second-quarter financial results should be strong, and could help the company recover from today's losses. 

Prosper Junior Bakiny has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Zynex, Inc. Stock Quote
Zynex, Inc.
ZYXI
$8.39 (-4.44%) $0.39

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
329%
 
S&P 500 Returns
106%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 09/25/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.